Orange Book product · Brand (NDA)
EPIDUO
ADAPALENE; BENZOYL PEROXIDE
At a glance
Dec 08, 2008
Approved
Brand (NDA)
Application
AB
TE code
3
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 08, 2008
17 yr 9 mo ago
Today
Patent 8071644 expires
Listed drug product patent expiration.
Jul 18, 2027
in 1 yr 1 mo
Patent 8080537 expires
Listed method-of-use patent (U-1078) expiration.
Jul 18, 2027
in 1 yr 1 mo
Patent 8129362 expires
Listed method-of-use patent (U-1078) expiration.
Jul 18, 2027
in 1 yr 1 mo
Pharmaceutical detail
Active ingredient
ADAPALENE; BENZOYL PEROXIDE
Strength
0.1%;2.5%
Dosage form
GEL
Route
TOPICAL
TE code
AB
Application
NDA 022320
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2026DIFFERIN EPIDUOBrand (NDA)
NDA 220736 · GALDERMA LABS LP
- 2015EPIDUO FORTEBrand (NDA)
NDA 207917 · GALDERMA LABS
- 2022ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 214185 · ALEMBIC
- 2022ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 209641 · ACTAVIS LABS UT INC
- 2022ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 214553 · ZYDUS PHARMS
- 2022ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 212464 · PADAGIS ISRAEL
- 2019ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 208108 · GLENMARK PHARMS LTD
- 2018ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 209148 · SUN PHARMA CANADA
- 2018ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 206164 · ENCUBE
- 2018ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 206959 · SUN PHARMA CANADA
- 2018ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 205033 · PADAGIS ISRAEL
- 2015ADAPALENE AND BENZOYL PEROXIDEGeneric (ANDA)
ANDA 203790 · ACTAVIS MID ATLANTIC
Listed patents (3)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8071644 | Jul 18, 2027 | in 1 yr 1 mo | ProductU-1078 |
| 8080537 | Jul 18, 2027 | in 1 yr 1 mo | U-1078 |
| 8129362 | Jul 18, 2027 | in 1 yr 1 mo | U-1078 |

